Idiopathic retroperitoneal fibrosis: clinical features and long-term renal function outcome

Zahran, Mohamed H; Osman, Yasser; Soltan, Mohamed A.; Abolazm, Ahmed Elhussein; Ghazy, Mostafa; Harraz, Ahmed M.; Shokeir, Ahmed A.; Abol‐Enein, Hassan; Ali-El-Dein, Bedeir

doi:10.1007/s11255-017-1608-9

Cited by 7 publications

(3 citation statements)

References 18 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ureteric obstruction can be amenable to both medical and surgical therapy; however, the latter often results in quicker resolution of symptoms. Surgical therapy could be in the form of temporizing maneuvers such as percutaneous nephrostomy or ureteric stent insertion (Figure 4 ), both of which the patient had; however, primary surgical management involves biopsy to confirm disease as well as ureterolysis and lateral/intraperitoneal transposition or omental wrapping of the involved ureter [ 5 , 6 ]. Urinary tract de-obstruction using ureteric double J stents was attempted, but this failed to achieve adequate urinary drainage with no significant improvement in the patient’s renal function, thus necessitating percutaneous nephrostomy insertion.…”

Section: Discussionmentioning

confidence: 99%

Bilateral Ureteric Obstruction Due to Retroperitoneal Fibrosis: A Case Report

Okpii¹,

Okpii²,

Adamu‐Biu³

2022

Cureus

View full text Add to dashboard Cite

Retroperitoneal fibrosis is a rare disease with a largely unknown aetiology, varying presentation, and is characterized by fibrous tissue formation in the retroperitoneal region. It causes entrapment and obstruction of retroperitoneal tubular structures, notably the ureters, and has been associated with autoimmune disorders. We report a 52-year-old male who was admitted to the emergency department with a seven-day history of lower abdominal pain, anorexia, and unintentional weight loss. Routine blood work revealed the patient to have acute kidney injury, and an unenhanced computed tomography scan of the abdomen showed bilateral hydronephrosis (grades 1 and 3 on the right and left, respectively) caused by a soft tissue mass in the retroperitoneal region. This mass was investigated with further imaging and a core biopsy, which confirmed retroperitoneal fibrosis. He is currently being planned for ureterolysis after a poor response to steroid therapy under the nephrology team. Urinary diversion was achieved with bilateral nephrostomies following unsatisfactory drainage with bilateral ureteric stents. This case highlights some of the difficulties that may be encountered in the management of retroperitoneal fibrosis.

show abstract

Section: Discussionmentioning

confidence: 99%

Bilateral Ureteric Obstruction Due to Retroperitoneal Fibrosis: A Case Report

Okpii¹,

Okpii²,

Adamu‐Biu³

2022

Cureus

View full text Add to dashboard Cite

show abstract

“…Patients with retroperitoneal fibrosis present with abdominal pain, jaundice, weight loss, and exocrine/endocrine pancreatic failure most commonly. 8 IgG4 disease is usually diagnosed on the basis of histopathological findings as there are no criteria for diagnosis of IgG4-related diseases. Patients with multiple organ involvement of IgG4-related disease usually have increased levels of IgG4.…”

Section: Discussionmentioning

confidence: 99%

Retroperitoneal Fibrosis as a presentation with masked multiorgan involvement of IgG4‐related disease—demystifying the diagnosis: A case report from Nepal

Shah

Chamlagain

Baral

et al. 2021

Clinical Case Reports

View full text Add to dashboard Cite

show abstract

“…Dans les séries publiées, environ la moitié des patients nécessite un drainage des urines en urgence. Dans de rares cas, une chirurgie ouverte peut être envisagée qui a l'avantage de permettre la réalisation d'une biopsie [29,30]. L'urétérolyse peut être proposée en cas de forte suspicion de forme secondaire et lorsque la biopsie par voie radiologique est difficile et/ou lorsque le traitement médical n'a pas permis de réduire la masse et qu'une obstruction des voies urinaires persiste [31,32].…”

Section: Traitementsunclassified